NDC properties for "testosterone 12.5 MG/ACTUAT Transdermal Gel Pump, 60 ACTUAT" (RxCUI 1596780)
About this data
The tables show NDC propoerties for testosterone 12.5 MG/ACTUAT Transdermal Gel Pump, 60 ACTUAT with the RxCUI 1596780
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone 12.5 MG/ACTUAT Transdermal Gel Pump, 60 ACTUAT (RxCUI 1596780)
ANDA | ANDA076737 |
---|---|
ANDA | ANDA212984 |
MMSL_CODE | BD22848 |
MMSL_CODE | CD22848 |
NDA | NDA203098 |
RxCUI | 1596780 |
SPL_SET_ID | 5834d34f-839d-412c-b74c-da1dad2cfa88 |
SPL_SET_ID | 7d655d6d-01da-488c-bd4e-c7fbe0ace38c |
SPL_SET_ID | a887020f-b41f-49fe-8379-f01147b2a796 |
SPL_SET_ID | fa29b98e-28a7-41f5-8fc7-718ea092de27 |
VUID | 4025004 |
VUID | 4030819 |
Prescribable Synonym | testosterone 1 % (12.5 MG/ACTUAT) Transdermal Gel Pump, 60 ACTUAT |
RXNAV_STR | 60 ACTUAT testosterone 12.5 MG/ACTUAT Topical Gel |
RxNorm Name | 60 ACTUAT testosterone 12.5 MG/ACTUAT Topical Gel |
RxNorm Synonym | testosterone 12.5 MG/ACTUAT Transdermal Gel Pump, 60 ACTUAT |
Related queries | Interactions (for RxCUI 1596780) |
NDC Properties
NDC Item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
Packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
Packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
Packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 797609 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 21922-019 |
NDC Item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
Packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
Packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
Packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 797609 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 21922-019 |
NDC Item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
Packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
Packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
Packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 797609 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 21922-019 |
NDC Item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
Packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
Packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
Packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 797609 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 21922-019 |
NDC Item 00591292102
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-02 |
NDC Item | 00591292102 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0591-2921-02) / 75 g in 1 BOTTLE, PUMP (0591-2921-18) |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00591292118
NDC 9 | 0591-2921 |
---|---|
NDC 10 | 0591-2921-18 |
NDC Item | 00591292118 |
Packaging | 75 g in 1 BOTTLE, PUMP |
ANDA | ANDA076737 |
DCSA | CIII |
FDA SPL set id | 701373 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2015-12-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 0591-2921 |
NDC Item 00832112140
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-40 |
NDC Item | 00832112140 |
Packaging | 60 in 1 BOTTLE, PUMP |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 00832112142
NDC 9 | 0832-1121 |
---|---|
NDC 10 | 0832-1121-42 |
NDC Item | 00832112142 |
Packaging | 2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40) |
COLORTEXT | WHITE(clear, transluscent) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 710489 |
Labeler | Upsher-Smith Laboratories, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA AUTHORIZED GENERIC |
Marketing effective time low | 2014-06-16 |
Marketing status | ACTIVE |
NDA_AUTHORIZED_GENERIC | NDA204399 |
Related queries | Properties for NDC 9 0832-1121 |
NDC Item 21922001947
NDC 9 | 21922-019 |
---|---|
NDC 10 | 21922-019-47 |
NDC Item | 21922001947 |
Packaging | 2 CONTAINER in 1 CARTON (21922-019-47) / 75 g in 1 CONTAINER |
ANDA | ANDA212984 |
DCSA | CIII |
FDA SPL set id | 797609 |
Labeler | Encube Ethicals Private Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |
Related queries | Properties for NDC 9 21922-019 |